Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Abstract 5471: Ribosome heterogeneity and RNA polI inhibition in osteosarcoma heterogeneity

Marc Baud'huin, Elvina Colleville, Rose Anne Thepault, Emilien Orgebin, Francois Lamoureux, Benjamin Ory

Cancer Res (2024) 84 (6_Supplement): 5471.

https://doi.org/10.1158/1538-7445.AM2024-5471

Published: 22 March 2024

View article titled, Abstract 5471: Ribosome heterogeneity and RNA polI inhibition in osteosarcoma heterogeneity

Journal Articles

Abstract 3902: TRIM33 interacts with HSF1 in osteosarcoma development

Morgane Lallier, Robel Tefaye, Brice Moukengué, Céline Charrier, Rose-Anne Thepault, Benedicte Brounais-Le Royer, Marc Baud'huin, Franck Verrecchia, Benjamin Ory, François Lamoureux

Cancer Res (2022) 82 (12_Supplement): 3902.

https://doi.org/10.1158/1538-7445.AM2022-3902

Published: 15 June 2022

View article titled, Abstract 3902: TRIM33 interacts with HSF1 in osteosarcoma development

Journal Articles

Abstract 6264: Mechanisms of resistance to doxorubicin in HOS-MNNG cell line

Robel A. Tesfaye, Mélanie Lavaud, Anaïs Postec, Céline Charrier, Rose-Anne Thépault, Franck Verrecchia, Marc Baud'huin, François Lamoureux, Steven Georges, Benjamin Ory

Cancer Res (2022) 82 (12_Supplement): 6264.

https://doi.org/10.1158/1538-7445.AM2022-6264

Published: 15 June 2022

View article titled, Abstract 6264: Mechanisms of resistance to doxorubicin in HOS-MNNG cell line

Journal Articles

Abstract 6325: Identification of genes responsible for osteosarcomas metastatic evolution by active super enhancers profiling

Mélanie Lavaud, Robel Tesfaye, Céline Charrier, Rose Anne Thépault, Maxime Golias, Sarah Le Page, Mathilde Mullard, Bénédicte Brounais, Franck Verrecchia, Marc Baud'huin, François Lamoureux, Steven Georges, Benjamin Ory

Cancer Res (2022) 82 (12_Supplement): 6325.

https://doi.org/10.1158/1538-7445.AM2022-6325

Published: 15 June 2022

View article titled, Abstract 6325: Identification of genes responsible for osteosarcomas metastatic evolution by active super enhancers profiling

Journal Articles

Abstract 4673: BET bromodomains epigenetic signaling in osteosarcoma: Localization of super-enhancers and identification of new therapeutic targets

Melanie Lavaud, Robel Tesfaye, Steven Georges, Marc Baud'huin, François Lamoureux, BENJAMIN ORY

Cancer Res (2020) 80 (16_Supplement): 4673.

https://doi.org/10.1158/1538-7445.AM2020-4673

Published: 15 August 2020

View article titled, Abstract 4673: BET bromodomains epigenetic signaling in osteosarcoma: Localization of super-enhancers and identification of new therapeutic targets

Journal Articles

Abstract 3595: Riboprotein variant and their role in chondrogenic differentiation and osteosarcoma development

Emilien Orgebin, Benjamin Ory, Francois Lamoureux, Marie-Francoise O'Donohue, Céline Charrier, Pierre-Emmanuel Gleizes, Bertrand Isidor, Marc Baud'huin

Cancer Res (2020) 80 (16_Supplement): 3595.

https://doi.org/10.1158/1538-7445.AM2020-3595

Published: 15 August 2020

View article titled, Abstract 3595: Riboprotein variant and their role in chondrogenic differentiation and osteosarcoma development

Journal Articles

Abstract 1911: ΔNp63α promotes TGFβ-induced metastasis by silencing a microRNA network restraining wound healing

Lidia Rodriguez Calleja, camille Jacques, Francois Lamoureux, Marc Baud’huin, Thibault Quillard, Franck Verrecchia, Dominique Heymann, Leif Ellisen, Benjamin Ory

Cancer Res (2016) 76 (14_Supplement): 1911.

https://doi.org/10.1158/1538-7445.AM2016-1911

Published: 15 July 2016

View article titled, Abstract 1911: ΔNp63α promotes TGFβ-induced metastasis by silencing a microRNA network restraining wound healing

Journal Articles

Abstract 4472: Targeting the oncogenic transcription factor EWS-Fli1 by BET bromodomain inhibition in Ewing sarcoma

Camille JACQUES, François LAMOUREUX, Marc BAUD’HUIN, Lidia RODRIGUEZ-CALLEJA, Thibaut QUILLARD, Pierre PERROT, Franck TIRODE, Françoise REDINI, James E. BRADNER, Dominique HEYMANN, Benjamin ORY

Cancer Res (2016) 76 (14_Supplement): 4472.

https://doi.org/10.1158/1538-7445.AM2016-4472

Published: 15 July 2016

View article titled, Abstract 4472: Targeting the oncogenic transcription factor EWS-Fli1 by BET bromodomain inhibition in Ewing sarcoma

Journal Articles

ΔNp63α Silences a miRNA Program to Aberrantly Initiate a Wound-Healing Program That Promotes TGFβ-Induced Metastasis

Lidia Rodriguez Calleja, Camille Jacques, François Lamoureux, Marc Baud'huin, Marta Tellez Gabriel, Thibaut Quillard, Debashish Sahay, Pierre Perrot, Jerome Amiaud, Celine Charrier, Regis Brion, Fernando Lecanda, Franck Verrecchia, Dominique Heymann, Leif W. Ellisen, Benjamin Ory

Cancer Res (2016) 76 (11): 3236–3251.

https://doi.org/10.1158/0008-5472.CAN-15-2317

Published: 31 May 2016

View article titled, ΔNp63α Silences a miRNA Program to Aberrantly Initiate a Wound-Healing Program That Promotes TGFβ-Induced Metastasis

Includes: Supplementary data

Journal Articles

Abstract B46: miRNA-193a-5p repression of p73 induces Cisplatine chemoresistance in bone-related sarcomas

Camille Jacques, François Lamoureux, Marc Baud'huin, Lidia Rodriguez Calleja, Dominique Heymann, Benjamin Ory

Cancer Res (2016) 76 (6_Supplement): B46.

https://doi.org/10.1158/1538-7445.NONRNA15-B46

Published: 13 May 2016

View article titled, Abstract B46: miRNA-193a-5p repression of p73 induces Cisplatine chemoresistance in bone-related sarcomas

Journal Articles

Abstract 1750: Preclinical efficacy of Hsp90 inhibition by using PF-04942847 in osteosarcoma

Marc Baud'Huin, Benjamin Ory, Franck Verrecchia, Dominique Heymann, Francoise Redini, Francois Lamoureux

Cancer Res (2015) 75 (15_Supplement): 1750.

https://doi.org/10.1158/1538-7445.AM2015-1750

Published: 01 August 2015

View article titled, Abstract 1750: Preclinical efficacy of Hsp90 inhibition by using PF-04942847 in osteosarcoma

Journal Articles

Abstract A50: Selective inhibition of BET bromodomains epigenetic signaling interferes with the bone-associated tumor vicious cycle

Francois Lamoureux, Marc Baud'huin, Lidia Rodriguez, Camille Jacques, Francoise Redini, James E. Bradner, Dominique Heymann, Benjamin Ory

Cancer Res (2014) 74 (20_Supplement): A50.

https://doi.org/10.1158/1538-7445.PEDCAN-A50

Published: 09 October 2014

View article titled, Abstract A50: Selective inhibition of BET bromodomains epigenetic signaling interferes with the bone-associated tumor vicious cycle

Journal Articles

Abstract LB-142: Selective inhibition of BET bromodomains epigenetic signaling interferes with the bone-associated tumor vicious cycle

Francois Lamoureux, Marc Baud'Huin, Lidia Rodriguez Calleja, Camille Jacques, Francoise Redini, James E. Bradner, Dominique Heymann, Benjamin Ory

Cancer Res (2014) 74 (19_Supplement): LB-142.

https://doi.org/10.1158/1538-7445.AM2014-LB-142

Published: 01 October 2014

View article titled, Abstract LB-142: Selective inhibition of BET bromodomains epigenetic signaling interferes with the bone-associated tumor vicious cycle

Journal Articles

Abstract B53: Selective BET bromodomains epigenetic signaling inhibition as a therapeutic strategy in primary bone tumors

Francois Lamoureux, Marc Baud'huin, Lidia Rodriguez, Camille Jacques, Martine Berreur, Francoise Rédini, James E. Bradner, Dominique Heymann, Benjamin Ory

Cancer Res (2013) 73 (13_Supplement): B53.

https://doi.org/10.1158/1538-7445.CEC13-B53

Published: 13 May 2014

View article titled, Abstract B53: Selective BET bromodomains epigenetic signaling inhibition as a therapeutic strategy in primary bone tumors

Journal Articles

Glycosaminoglycans as Potential Regulators of Osteoprotegerin Therapeutic Activity in Osteosarcoma

Francois Lamoureux, Gaëlle Picarda, Laure Garrigue-Antar, Marc Baud'huin, Valerie Trichet, André Vidal, Elisabeth Miot-Noirault, Bruno Pitard, Dominique Heymann, Françoise Rédini

Cancer Res (2009) 69 (2): 526–536.

https://doi.org/10.1158/0008-5472.CAN-08-2648

Published: 15 January 2009

View article titled, Glycosaminoglycans as Potential Regulators of Osteoprotegerin Therapeutic Activity in Osteosarcoma

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 5471: Ribosome heterogeneity and RNA polI inhibition in osteosarcoma heterogeneity

Abstract 3902: TRIM33 interacts with HSF1 in osteosarcoma development

Abstract 6264: Mechanisms of resistance to doxorubicin in HOS-MNNG cell line

Abstract 6325: Identification of genes responsible for osteosarcomas metastatic evolution by active super enhancers profiling

Abstract 4673: BET bromodomains epigenetic signaling in osteosarcoma: Localization of super-enhancers and identification of new therapeutic targets

Abstract 3595: Riboprotein variant and their role in chondrogenic differentiation and osteosarcoma development

Abstract 1911: ΔNp63α promotes TGFβ-induced metastasis by silencing a microRNA network restraining wound healing

Abstract 4472: Targeting the oncogenic transcription factor EWS-Fli1 by BET bromodomain inhibition in Ewing sarcoma

ΔNp63α Silences a miRNA Program to Aberrantly Initiate a Wound-Healing Program That Promotes TGFβ-Induced Metastasis

Abstract B46: miRNA-193a-5p repression of p73 induces Cisplatine chemoresistance in bone-related sarcomas

Abstract 1750: Preclinical efficacy of Hsp90 inhibition by using PF-04942847 in osteosarcoma

Abstract A50: Selective inhibition of BET bromodomains epigenetic signaling interferes with the bone-associated tumor vicious cycle

Abstract LB-142: Selective inhibition of BET bromodomains epigenetic signaling interferes with the bone-associated tumor vicious cycle

Abstract B53: Selective BET bromodomains epigenetic signaling inhibition as a therapeutic strategy in primary bone tumors

Glycosaminoglycans as Potential Regulators of Osteoprotegerin Therapeutic Activity in Osteosarcoma

Email alerts

AACR Journals

Resources

AACR Journals
on Social Media

Update search

Email alerts

AACR Journals

Resources

AACR Journals on Social Media

This Feature Is Available To Subscribers Only

AACR Journals
on Social Media